Decoding semi-automated title-abstract screening: findings from a convenience sample of reviews.
Artificial intelligence
Efficiency
Machine learning
Methods
Systematic reviews
Text mining
Journal
Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575
Informations de publication
Date de publication:
27 11 2020
27 11 2020
Historique:
received:
08
07
2020
accepted:
11
11
2020
entrez:
27
11
2020
pubmed:
28
11
2020
medline:
25
6
2021
Statut:
epublish
Résumé
We evaluated the benefits and risks of using the Abstrackr machine learning (ML) tool to semi-automate title-abstract screening and explored whether Abstrackr's predictions varied by review or study-level characteristics. For a convenience sample of 16 reviews for which adequate data were available to address our objectives (11 systematic reviews and 5 rapid reviews), we screened a 200-record training set in Abstrackr and downloaded the relevance (relevant or irrelevant) of the remaining records, as predicted by the tool. We retrospectively simulated the liberal-accelerated screening approach. We estimated the time savings and proportion missed compared with dual independent screening. For reviews with pairwise meta-analyses, we evaluated changes to the pooled effects after removing the missed studies. We explored whether the tool's predictions varied by review and study-level characteristics. Using the ML-assisted liberal-accelerated approach, we wrongly excluded 0 to 3 (0 to 14%) records that were included in the final reports, but saved a median (IQR) 26 (9, 42) h of screening time. One missed study was included in eight pairwise meta-analyses in one systematic review. The pooled effect for just one of those meta-analyses changed considerably (from MD (95% CI) - 1.53 (- 2.92, - 0.15) to - 1.17 (- 2.70, 0.36)). Of 802 records in the final reports, 87% were correctly predicted as relevant. The correctness of the predictions did not differ by review (systematic or rapid, P = 0.37) or intervention type (simple or complex, P = 0.47). The predictions were more often correct in reviews with multiple (89%) vs. single (83%) research questions (P = 0.01), or that included only trials (95%) vs. multiple designs (86%) (P = 0.003). At the study level, trials (91%), mixed methods (100%), and qualitative (93%) studies were more often correctly predicted as relevant compared with observational studies (79%) or reviews (83%) (P = 0.0006). Studies at high or unclear (88%) vs. low risk of bias (80%) (P = 0.039), and those published more recently (mean (SD) 2008 (7) vs. 2006 (10), P = 0.02) were more often correctly predicted as relevant. Our screening approach saved time and may be suitable in conditions where the limited risk of missing relevant records is acceptable. Several of our findings are paradoxical and require further study to fully understand the tasks to which ML-assisted screening is best suited. The findings should be interpreted in light of the fact that the protocol was prepared for the funder, but not published a priori. Because we used a convenience sample, the findings may be prone to selection bias. The results may not be generalizable to other samples of reviews, ML tools, or screening approaches. The small number of missed studies across reviews with pairwise meta-analyses hindered strong conclusions about the effect of missed studies on the results and conclusions of systematic reviews.
Sections du résumé
BACKGROUND
We evaluated the benefits and risks of using the Abstrackr machine learning (ML) tool to semi-automate title-abstract screening and explored whether Abstrackr's predictions varied by review or study-level characteristics.
METHODS
For a convenience sample of 16 reviews for which adequate data were available to address our objectives (11 systematic reviews and 5 rapid reviews), we screened a 200-record training set in Abstrackr and downloaded the relevance (relevant or irrelevant) of the remaining records, as predicted by the tool. We retrospectively simulated the liberal-accelerated screening approach. We estimated the time savings and proportion missed compared with dual independent screening. For reviews with pairwise meta-analyses, we evaluated changes to the pooled effects after removing the missed studies. We explored whether the tool's predictions varied by review and study-level characteristics.
RESULTS
Using the ML-assisted liberal-accelerated approach, we wrongly excluded 0 to 3 (0 to 14%) records that were included in the final reports, but saved a median (IQR) 26 (9, 42) h of screening time. One missed study was included in eight pairwise meta-analyses in one systematic review. The pooled effect for just one of those meta-analyses changed considerably (from MD (95% CI) - 1.53 (- 2.92, - 0.15) to - 1.17 (- 2.70, 0.36)). Of 802 records in the final reports, 87% were correctly predicted as relevant. The correctness of the predictions did not differ by review (systematic or rapid, P = 0.37) or intervention type (simple or complex, P = 0.47). The predictions were more often correct in reviews with multiple (89%) vs. single (83%) research questions (P = 0.01), or that included only trials (95%) vs. multiple designs (86%) (P = 0.003). At the study level, trials (91%), mixed methods (100%), and qualitative (93%) studies were more often correctly predicted as relevant compared with observational studies (79%) or reviews (83%) (P = 0.0006). Studies at high or unclear (88%) vs. low risk of bias (80%) (P = 0.039), and those published more recently (mean (SD) 2008 (7) vs. 2006 (10), P = 0.02) were more often correctly predicted as relevant.
CONCLUSION
Our screening approach saved time and may be suitable in conditions where the limited risk of missing relevant records is acceptable. Several of our findings are paradoxical and require further study to fully understand the tasks to which ML-assisted screening is best suited. The findings should be interpreted in light of the fact that the protocol was prepared for the funder, but not published a priori. Because we used a convenience sample, the findings may be prone to selection bias. The results may not be generalizable to other samples of reviews, ML tools, or screening approaches. The small number of missed studies across reviews with pairwise meta-analyses hindered strong conclusions about the effect of missed studies on the results and conclusions of systematic reviews.
Identifiants
pubmed: 33243276
doi: 10.1186/s13643-020-01528-x
pii: 10.1186/s13643-020-01528-x
pmc: PMC7694314
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
272Références
Syst Rev. 2019 Jul 11;8(1):163
pubmed: 31296265
PLoS Med. 2016 May 24;13(5):e1002028
pubmed: 27218655
BMC Med Res Methodol. 2020 Jun 3;20(1):139
pubmed: 32493228
Syst Rev. 2019 Jun 18;8(1):143
pubmed: 31215463
PLoS Med. 2010 Sep 21;7(9):e1000326
pubmed: 20877712
Res Synth Methods. 2018 Sep;9(3):470-488
pubmed: 29956486
J Clin Epidemiol. 2020 May;121:81-90
pubmed: 32004673
Syst Rev. 2018 Jan 09;7(1):3
pubmed: 29316980
Ann Intern Med. 2017 Aug 1;167(3):213-215
pubmed: 28605762
Syst Rev. 2018 Mar 12;7(1):45
pubmed: 29530097
Syst Rev. 2019 Nov 15;8(1):278
pubmed: 31727150
Syst Rev. 2015 Nov 12;4:160
pubmed: 26563648
Syst Rev. 2020 Oct 19;9(1):243
pubmed: 33076975
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131
Ann Intern Med. 2007 Aug 21;147(4):224-33
pubmed: 17638714
Syst Rev. 2012 Feb 10;1:10
pubmed: 22587960
Res Synth Methods. 2018 Dec;9(4):602-614
pubmed: 29314757
Syst Rev. 2015 Jan 14;4:5
pubmed: 25588314
BMC Med. 2015 Sep 16;13:224
pubmed: 26377409
BMC Bioinformatics. 2010 Jan 26;11:55
pubmed: 20102628
BMJ. 2017 Sep 21;358:j4008
pubmed: 28935701
Syst Rev. 2018 May 19;7(1):77
pubmed: 29778096
Syst Rev. 2019 Nov 15;8(1):277
pubmed: 31727159
BMJ Open. 2017 Feb 27;7(2):e012545
pubmed: 28242767
Syst Rev. 2015 Jun 15;4:78
pubmed: 26073888
Res Synth Methods. 2017 Sep;8(3):275-280
pubmed: 28374510
Syst Rev. 2014 Jul 09;3:74
pubmed: 25005128
Syst Rev. 2015 Jun 15;4:80
pubmed: 26073974
Syst Rev. 2020 Apr 2;9(1):73
pubmed: 32241297
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
J Clin Epidemiol. 2018 Nov;103:101-111
pubmed: 30297037